Immediate Impact
61 standout
Citing Papers
From ex vivo to in vivo chimeric antigen T cells manufacturing: new horizons for CAR T-cell based therapy
2025 Standout
Digestive cancers: mechanisms, therapeutics and management
2025 Standout
Works of Nathaniel Smith being referenced
The Cost-Effectiveness of Axicabtagene Ciloleucel as Second-Line Therapy in Patients with Large B-Cell Lymphoma in the United States: An Economic Evaluation of the ZUMA-7 Trial
2022
Real-world cost-effectiveness of stool-based colorectal cancer screening in a Medicare population
2021
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Nathaniel Smith | 131 | 122 | 60 | 66 | 25 | 285 | |
| Ross Murtagh | 111 | 71 | 66 | 107 | 15 | 293 | |
| Vincenzo Sangiovanni | 85 | 61 | 38 | 116 | 22 | 284 | |
| Jorge Valencia | 177 | 104 | 28 | 129 | 25 | 300 | |
| Luigi Atripaldi | 69 | 56 | 59 | 139 | 38 | 327 | |
| Cunling Yan | 119 | 116 | 51 | 59 | 24 | 326 | |
| Vanessa De Pace | 79 | 76 | 19 | 93 | 33 | 324 | |
| Patrizia Caligiuri | 170 | 127 | 14 | 113 | 20 | 289 | |
| Pei‐Hung Chuang | 137 | 20 | 15 | 116 | 25 | 313 | |
| Lingjun Chen | 68 | 12 | 39 | 69 | 25 | 308 | |
| Tim Kümmerle | 141 | 85 | 7 | 106 | 20 | 218 |
All Works
Login with ORCID to disown or claim papers
Loading papers...